CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.3333
+0.01
(+4.06%)
After-Hours: 19:06
CollPlant Biotechnologies Profit Margin (Quarterly) : -4.24K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -4.24K% |
| December 31, 2025 | -5.34K% |
| September 30, 2025 | -4.52K% |
| June 30, 2025 | -1.87K% |
| March 31, 2025 | -70.66% |
| December 31, 2024 | -2.36K% |
| September 30, 2024 | -108.2K% |
| June 30, 2024 | -1.69K% |
| March 31, 2024 | -4.28K% |
| December 31, 2023 | -1.57K% |
| September 30, 2023 | -10.18K% |
| June 30, 2023 | 56.58% |
| March 31, 2023 | -858.0% |
| December 31, 2022 | -7.59K% |
| September 30, 2022 | -4.02K% |
| June 30, 2022 | -6.49K% |
| March 31, 2022 | -5.85K% |
| December 31, 2021 | -1.22K% |
| September 30, 2021 | -2.20K% |
| June 30, 2021 | -439.7% |
| March 31, 2021 | 69.82% |
| December 31, 2020 | -521.5% |
| September 30, 2020 | 16.95% |
| June 30, 2020 | -239.5% |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | -467.9% |
| June 30, 2019 | -205.9% |
| March 31, 2019 | -343.1% |
| December 31, 2018 | 23.93% |
| September 30, 2018 | -596.1% |
| June 30, 2018 | -854.1% |
| March 31, 2018 | -929.2% |
| December 31, 2017 | -621.1% |
| September 30, 2017 | -1.50K% |
| June 30, 2017 | -2.91K% |
| March 31, 2017 | -2.06K% |
| December 31, 2016 | -3.52K% |
| September 30, 2016 | -7.42K% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 10.15% |
| Perspective Therapeutics, Inc. | -33.31K% |
| MiMedx Group, Inc. | -23.06% |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -145.4% |
| Return on Assets | -95.59% |
| Return on Invested Capital | -110.4% |
| Gross Profit Margin (Quarterly) | -620.5% |
| Operating Margin (Quarterly) | -4.27K% |
| Return on Net Operating Assets | -267.2% |